Elsevier

Behavioural Brain Research

Volume 333, 30 August 2017, Pages 118-122
Behavioural Brain Research

Prefrontal mRNA expression of long and short isoforms of D2 dopamine receptor: Possible role in delayed learning deficit caused by early life interleukin-1β treatment

https://doi.org/10.1016/j.bbr.2017.06.052Get rights and content

Highlights

  • D2L & D2S mRNAs were differentially regulated by learning & early life IL-1β treatment.

  • D2L mRNA was downregulated in the rat mPFC during active avoidance training.

  • Early life IL-1β treatment cancelled the learning-induced changes in D2L mRNA level.

  • D2S mRNA level negatively correlated with learning ability in control but not IL-1β-treated rats.

Abstract

Long (D2L) and short (D2S) isoform of the D2 dopamine receptor are believed to play different roles in behavioral regulation. However, little is known about differential regulation of these isoforms mRNA expression during the process of learning in physiological and pathological states. In this study, we have investigated the combined effect of training in active avoidance (AA) paradigm and chronic early life treatment with pro-inflammatory cytokine interleukin (IL)-1β (1 μg/kg i.p., P15-21) on D2S and D2L dopamine receptor mRNA expression in the medial prefrontal cortex (mPFC) of adult rats. We have shown differential regulation of D2 short and long mRNA isoform expression in the mPFC. There was no effect of AA-training on D2S mRNA expression, while D2L mRNA was downregulated in AA-trained control (intact and saline-treated) animals, and this effect was not observed in rats treated with IL-1β. D2S mRNA expression level negatively correlated with learning ability within control (saline-treated and intact) groups but not in IL-1β-treated animals. Thus, prefrontal expression of distinct D2 dopamine receptor splice variants is supposed to be implicated in cognitive decline caused by early life immune challenge.

Introduction

D2 dopamine receptors (DRs) are known to be implicated in different neuropsychiatric pathologies such as schizophrenia, attention deficit hyperactivity disorder, addictions, Parkinson disease, affective disorders [1], [2]. Short (D2S) and long (D2L) isoforms are produced by alternative mRNA splicing [3], [4] and differ by downstream intracellular signal pathways [5], [6], [7], [8] and synaptic localization: the D2L DRs are mainly distributed at postsynaptic sites, while D2S DRs have predominant presynaptic localization [9]. These two isoforms of D2 DR are believed to play different roles in the regulation of cognitive functions as human intronic single nucleotide polymorphisms (SNPs) affecting alternative splicing of D2 DR mRNA have been shown to modulate working memory processes, prefrontal and motor cortical activity, striatal functions and mood regulation [10], [11], [12], [13]. Animal studies performed on D2L knockout mice revealed D2L DR involvement in emotional response to novel stimuli, motor function regulation, control of behavioral flexibility [14], [15], [16], [17], [18]. A post mortem study has shown an association between D2S/D2L mRNA ratio and psychiatric diseases such as schizophrenia and affective disorders [19]. Despite the emerging data concerning the functions of D2L and D2S DRs in the CNS, differential regulation of D2 DR splice isoforms expression and its contribution to cognitive performance and brain pathology are underexplored.

The disruption of brain DAergic system development is known to be implicated in various neurodevelopmental disorders [20], [21], i.e. brain dysfunctions caused by detrimental intrinsic and/or environmental factors in vulnerable periods of CNS development [22], [23], [24]. Elevation of pro-inflammatory cytokine level, including interleukin-1β (IL-1β), in the blood and CNS during vulnerable periods of early life is believed to be detrimental for brain maturation [22], [24], [25]. A number of studies have revealed that early life increase of IL-1β may affect development of DAergic neurons as well as produce behavioral dysfunctions in later life [26], [27], [28], [29], [30], [31], [32]. Early life immune challenge accompanied by IL-1β elevation has been shown to induce changes in D2 DR expression within different brain areas [33], [34], [35], whereas how it contributes to individual splice variants remains unclear.

The influence of active avoidance training on mRNA expression level of long and short D2 DR isoforms in the medial prefrontal cortex of rats including animals with impaired cognitive performance was investigated in the present study. We used chronic early life treatment with moderately pyrogenic doses of pro-inflammatory cytokine IL-1β as the model of mild cognitive impairments affecting active avoidance conditioning [28].

Section snippets

Experimental design

The D2L and D2S mRNA expression was evaluated in the mPFC of adult naive rats and animals trained in active avoidance conditioning paradigm. One group of animals used was chronically treated with moderate pyrogenic doses of IL-1β during the 3rd week of life (Fig. 1A). Our previous studies have shown such early life treatment to impair learning ability in active avoidance paradigm as well as learning-induced neurochemical disruptions in the mPFC of adult rats [28], [36]. Active avoidance

Learning ability of animals in active avoidance paradigm

We have evaluated the learning ability of neonatally treated with saline, IL-1β and untreated rats, used in DR expression analysis experiments (Fig. 2). We have revealed that the average number of avoidances (total for Days 2–5) was lower in adult rats treated with Il-1β during the 3rd week of life (Fig. 2). This tendency is very similar to that described earlier [28]. RM-ANOVA revealed significant effect of training day on number of avoidances (F(3) = 3.07 p = 0.039, Fig. 2), indicating that

Discussion

It is well known that mesocortical DAergic circuit (i.e. neurons of ventral tegmental area innervating the mPFC) plays crucial role in memory, emotional, and reward processes, attention and reaction to stress [43], [44], [45]. Differential signaling provided by different DR types in the mPFC influences cognitive performance; accordingly, alternations in distinct DR expression potentially result in cognitive impairments [45]. Prefrontal D2-like receptors are believed to have preferential role in

Conclusions

Taken together, the present study indicates that the differential regulation of D2 DR isoforms mRNA expression in the mPFC by the process of learning is disrupted in adult animals after chronic early life treatment with IL-1β, suggesting that dysregulation of D2 DR mRNA expression in this brain area may be one of the mechanisms of impaired neuroplasticity and cognitive decline caused by early life immune challenge.

Acknowledgements

This work was supported by the Russian Foundation for Basic Research [grant numbers 16-34-00873 mol_a; 17-04-02116 А] and the Federal Agency of Scientific Organizations (Russia).

References (49)

  • T.M. Tzschentke

    Pharmacology and behavioral pharmacology of the mesocortical dopamine system

    Prog. Neurobiol.

    (2001)
  • R. Pakdel et al.

    Microinjections of the dopamine D2 receptor antagonist sulpiride into the medial prefrontal cortex attenuate glucocorticoid-induced impairment of long-term memory retrieval in rats

    Neurobiol. Learn. Mem.

    (2007)
  • M.J. Frank et al.

    Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms

    Neuroscience

    (2009)
  • J. Beaulieu et al.

    The physiology, signaling, and pharmacology of dopamine receptors

    Pharmacol. Rev.

    (2011)
  • P. Seeman

    All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors

    CNS Neurosci. Ther.

    (2011)
  • B. Giros et al.

    Alternative splicing directs the expression of two D2 dopamine receptor isoforms

    Nature

    (1989)
  • F.J. Monsma et al.

    Multiple D2 dopamine receptors produced by alternative RNA splicing

    Nature

    (1989)
  • N. Lindgren et al.

    Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites

    Proc. Natl. Acad. Sci. U. S. A.

    (2003)
  • I.I. Van-Ham et al.

    Differential signaling of dopamine-D2S and -D2L receptors to inhibit ERK1/2 phosphorylation

    J. Neurochem.

    (2007)
  • S.C. Gantz et al.

    Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium

    Elife

    (2015)
  • Y. Takeuchi et al.

    Different activation of NF-κB by stimulation of dopamine D2L and D2S receptors through calcineurin activation

    J. Neurochem.

    (2004)
  • Z.U. Khan et al.

    Prominence of the dopamine D2 short isoform in dopaminergic pathways

    Proc. Natl. Acad. Sci. U. S. A.

    (1998)
  • A. Bertolino et al.

    Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia

    Brain

    (2009)
  • A. Bertolino et al.

    Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance

    PLoS One

    (2010)
  • Cited by (0)

    View full text